CEF30, Epstein-Barr Virus BRLF1 (134-142)

EBV BRLF1(134-142) is an HLA-A11-restricted epitope from the immediate-early Rta transactivator. It is useful for studying CTL responses to lytic EBV antigens and HLA-restricted immune recognition.

• immunology and infectious-disease research
• T-cell or innate-immune assays
• host-pathogen interaction studies
• antimicrobial or antigen-presentation research

Exact sequence, HLA restriction, disulfide connectivity, spacer chemistry and fluorescent labeling define the reagent. Use sequence- and modification-matched controls in quantitative assays.

1. Selected peer-reviewed publication